Cargando…

Assessment of a collaborative treatment model for trimodal management of esophageal cancer

BACKGROUND: Patients with esophageal cancer often receive care in a collaborative (multi-institutional) treatment model as opposed to a single institutional model. The effect of a collaborative model on the quality of trimodality therapy and survival is unknown. METHODS: The National Cancer Database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udelsman, Brooks V., Ermer, Theresa, Ely, Sora, Canavan, Maureen E., Zhan, Peter, Boffa, Daniel J., Blasberg, Justin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586936/ https://www.ncbi.nlm.nih.gov/pubmed/37868899 http://dx.doi.org/10.21037/jtd-23-346

Ejemplares similares

Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022)

Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022)

Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)

Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
por: Zhan, Peter Lee, et al.
Publicado: (2022)

The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases
por: Salazar, Michelle C., et al.
Publicado: (2021)

Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis
por: Li, Andrew X., et al.
Publicado: (2021)

Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)

Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications
por: Kaminski, Michael F., et al.
Publicado: (2022)

Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study
por: Pathak, Ranjan, et al.
Publicado: (2021)

Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
por: Ermer, Theresa, et al.
Publicado: (2022)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma
por: Igbo, Benjamin Terfa, et al.
Publicado: (2022)

Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers
por: Bang, Andrew, et al.
Publicado: (2019)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery
por: Papageorge, Marianna V, et al.
Publicado: (2020)

ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022)

Personalized trimodal prehabilitation for gastrectomy
por: Bausys, Augustinas, et al.
Publicado: (2020)

Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
por: Alfaifi, Salem, et al.
Publicado: (2021)

Commentary: Adjuvant chemotherapy after trimodal therapy for esophageal carcinoma: A bitter pill to swallow
por: Du, Valerie X., et al.
Publicado: (2020)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
por: W. Kim, Daniel, et al.
Publicado: (2020)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Bipolar disorder: Trimodal age‐at‐onset distribution
por: Bolton, Sorcha, et al.
Publicado: (2020)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Lung cancer with air lucency: a systematic review and clinical management guide
por: Detterbeck, Frank C., et al.
Publicado: (2023)

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial
por: Hauswald, Henrik, et al.
Publicado: (2015)

Trimodal Therapy: A Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia (Adv. Sci. 8/2018)
por: Luan, Xin, et al.
Publicado: (2018)

Time to Surgery for Patients with Esophageal Cancer Undergoing Trimodal Therapy in Ontario: A Population-Based Cross-Sectional Study
por: Hanna, Nader M., et al.
Publicado: (2022)

‘CROSS’-ing into the ‘Real World’: a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer
por: Higgins, Luke M., et al.
Publicado: (2023)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

Clinical outcomes of pancoast tumors treated with trimodality therapy
por: Lin, Tami Yu-Yu, et al.
Publicado: (2021)

Trimodality therapy of malignant pleural mesothelioma with helical tomotherapy
por: Ozyurt, Hazan, et al.
Publicado: (2023)

Role of FDG-PET/CT in prediction of pathological tumor response and survival after trimodality therapy for esophageal squamous cell carcinoma
por: Hamai, Yoichi, et al.
Publicado: (2015)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Multimodal Fingerprints of Resting State Networks as assessed by Simultaneous Trimodal MR-PET-EEG Imaging
por: Shah, N. J., et al.
Publicado: (2017)

Early results of a trimodality treatment for superior sulcus tumors
por: Łapiński, Mariusz, et al.
Publicado: (2014)

Developing Hollow-Channel Gold Nanoflowers as Trimodal Intracellular Nanoprobes
por: Ye, Sunjie, et al.
Publicado: (2018)

Trimodal Race Model Inequalities in Multisensory Integration: I. Basics
por: Colonius, Hans, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e2sjcg83i390akuvflpmtts1uf